BioSpace News Archive

The shareholders in RaySearch Laboratories AB, corporate identity no. 556322-6157, are hereby invited to the Annual General Meeting, to be held on Tuesday, June 30, 2020, at 4:00 p.m., at the company’s offices at Sveavägen 44, 7th floor, Stockholm, Sweden.

OraSure Technologies, Inc., a leader in point of care diagnostic tests and specimen collection devices, and microbiome laboratory and analytical services, announced that Dr. Stephen S. Tang, Ph.D., President and CEO, will speak to the investment community at the Jefferies 2020 Healthcare Conference.

Terns Pharmaceuticals, Inc., a global biopharmaceutical company focused on discovering and developing innovative therapies to treat liver disease and cancer, announced that Erin Quirk, M.D., Chief Medical Officer, will present a corporate overview and update on the Company’s lead clinical programs at the Jefferies Virtual Healthcare Conference taking place June 2-4, 2020.

Additionally, Announces Accretive Acquisition of ActivStyle, a Home Medical Supply Provider

Emgality® significantly improved work productivity and reduced interictal burden, defined as health and well-being between migraine attacks, in an analysis of the 3-month double-blind period of the CONQUER study, which included patients with migraine from 12 different countries.

Merck (NYSE: MRK), known as MSD outside the United States and Canada, will today announce three significant scientific initiatives to combat COVID-19: two agreements to develop potential vaccines against SARS-CoV-2, and a research collaboration to advance the development of a novel antiviral candidate. Today’s announcements are: Merck to acquire Themis Bioscience, a company focused on vaccines and immune-modulati

Sensor Electronic Technology, Inc. (“SETi”), the World’s first compound semiconductor for UV LED solutions (Violeds) and Seoul Viosys (KOSDAQ: 092190)’ subsidiary, announced that it launches portable air purifiers with Violeds technology, brand “VAC”, to reduce infection from various harmful bacteria including new coronavirus (SARS-CoV-2) in the air. The online sales of the products will be started in both South Korea and

Concert Pharmaceuticals, Inc. announced that Roger Tung, Ph.D., President and Chief Executive Officer, will be participating in a fireside chat at the Jefferies Virtual Global Healthcare Conference on June 2, 2020, at 2:00 p.m. ET.

Rigel Pharmaceuticals, Inc. announced that Raul Rodriguez, the company’s president and chief executive officer, is scheduled to present a company overview at the Jefferies Virtual Healthcare Conference on Wednesday, June 3, 2020 at 1:30 p.m. Eastern Time.

miRagen Therapeutics, Inc. announced that William S. Marshall, Ph.D., President and Chief Executive Officer of miRagen, will present at the Jefferies Virtual Global Healthcare Conference on Tuesday, June 2, 2020 at 4:00 p.m. ET.